ClinicalTrials.gg
Sign In

Granulomatous Disease, Chronic clinical trials

The registry lists 79 studies for Granulomatous Disease, Chronic across more than 10 countries. 17 are recruiting or about to start. 54 of them are mainly about Granulomatous Disease, Chronic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Granulomatous Disease, Chronic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
31
Terminated
14
Recruiting
12
Status unknown
6
Active, not recruiting
6
Withdrawn
5

Phase

Phase 2
38
Phase 1
33
Early Phase 1
5
Phase 3
3
Phase 4
2

Where

United States
58
United Kingdom
5
China
4
Canada
3
Germany
3
Switzerland
2

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (31) · Paul Szabolcs (4) · University of Colorado, Denver (2) · Ensoma (2) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (2) · Genethon (2) · Emory University (2) · Children's Hospital of Fudan University (2)

What is being tested here

Drugs under test in Granulomatous Disease, Chronic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Busulfan207
Alemtuzumab205
Sirolimus202
Fludarabine105
Melphalan102
Plerixafor102
Tocilizumab101
Eltrombopag101
Fibroblast Growth Factor 7101
Filgrastim101

Drug classes tested here Alkylating agents 3 open · Antimetabolites 1 open

Coming up

0phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 12 Granulomatous Disease, Chronic studies recruiting now, 3 (25%) set no upper age limit and 9 (75%) stop at 75 or younger. 8 (67%) take children under 18. 0 (0%) are for women only and 3 (25%) for men only; 2 (17%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
108 (67%)8 (67%)
189 (75%)12 (100%)
308 (67%)11 (92%)
408 (67%)11 (92%)
507 (58%)9 (75%)
655 (42%)7 (58%)
753 (25%)5 (42%)
853 (25%)3 (25%)

Across all 79 studies, recruiting or not: 56% stop at 75 or younger and 49% at 65; 85% take children; 0% are for women only and 15% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 79. Browse all 79 → or search them.